Key result
Thoracic aortic aneurysm is not associated with differences in aortic augmentation index versus matched controls.
Why the study?
Increased central arterial stiffness has been proposed in patients with thoracic aortic aneurysms compared to unmatched controls, but wall properties compared to matched controls remained unassessed.
Does central arterial stiffness (measured by augmentation index) differ between patients with thoracic aortic aneurysm and matched controls?
Case-Control (n=148)
No
Does central arterial stiffness (measured by augmentation index) differ between patients with thoracic aortic aneurysm and matched controls?
Mean Difference: 0.58 (95% CI -3.44–4.6)
Absolute Event Rate: 24.7% vs 22.8%
p-value: p=0.240
Patients with thoracic aortic aneurysm have comparable central arterial stiffness to matched controls, suggesting that previously reported increases in stiffness may have been confounded by unmatched cardiovascular risk factors.
Central stiffness comparable after risk-factor matching in thoracic aortic aneurysm; challenges prior unadjusted reports and leaves open confounding.
Thoracic aortic aneurysms (TAA) may be associated with complications such as rupture and dissection, which can lead to a fatal outcome. Increased central arterial stiffness has been proposed to be present in patients with TAA compared to unmatched controls. We aimed to assess whether wall properties in patients with TAA are also altered when compared to a matched control group. Applanation tonometry was performed in 74 adults with TAA and 74 sex, age, weight, height, and left ventricular ejection fraction matched controls. Subsequently analysis of the pulse wave was done using the SphygmoCor System. For comparing the two groups, AIx was adjusted to a heart rate of 75/min (AIx@75). 148 1-to-1 matched participants were included in the final model. There was no significant difference in the Alx@75 between the TAA group and the matched control group [mean (SD) of 24.7 (11.2) % and 22.8 (11.2) %, p = 0.240]. Adjusted for known cardiovascular risk factors, there was no association between TAA and AIx@75. Patients with TAA showed comparable arterial wall properties to cardiovascular risk factor matched controls. Since higher arterial stiffness is associated with TAA progression, it remains to be investigated if increased central arterial stiffness is a relevant factor of TAA emergence.
No takes yet. Share an insight, caveat, or question.
Baumgartner et al. (2022) conducted a case-control in Thoracic aortic aneurysm (TAA) (n=148). Thoracic aortic aneurysm (TAA) vs. Matched controls without aortic dilatation was evaluated on Aortic augmentation index adjusted to a heart rate of 75 beats per minute (AIx@75) (Adjusted Coef. 0.58, 95% CI -3.44 to 4.60, p=0.240). Patients with thoracic aortic aneurysm showed no significant difference in heart rate-adjusted aortic augmentation index (AIx@75) compared to matched controls (24.7% vs. 22.8%, p = 0.240).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: